Jazz Pharma’s Matthew Young to Join Grail as COO & CFO

Matthew Young has been appointed chief operating officer and chief financial officer of Grail. He will start his new job at the Menlo Park, CA-based liquid biopsy developer on Oct. 28. Young is coming to Grail from Jazz Pharmaceuticals (NASDAQ: [[ticker:JAZZ]]), where he is executive vice president and chief financial officer. His new appointment is the latest C-suite move for Grail this year. In June, Jennifer Cook stepped down as CEO and was succeeded by board member Hans Bishop. Grail is developing blood tests intended to detect cancer early from DNA fragments shed by tumors.

Author: Frank Vinluan

Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.